Suppr超能文献

在化疗期间为早期乳腺癌患者开具运动处方:一种与化疗周期相吻合的简单周期性方法。

Prescribing Exercise in Early-Stage Breast Cancer During Chemotherapy: A Simple Periodized Approach to Align With the Cyclic Phases of Chemotherapy.

机构信息

Department of Sports Cardiology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.

Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, VIC, Australia.

出版信息

J Strength Cond Res. 2022 Oct 1;36(10):2934-2941. doi: 10.1519/JSC.0000000000003990. Epub 2021 Feb 26.

Abstract

Bigaran, A, Howden, EJ, Foulkes, S, Janssens, K, Beaudry, R, Haykowsky, MJ, La Gerche, A, Fraser, SF, and Selig, SE. Prescribing exercise in early-stage breast cancer during chemotherapy: a simple periodized approach to align with the cyclic phases of chemotherapy. J Strength Cond Res 36(10): 2934-2941, 2022-To evaluate whether a periodized aerobic and resistance training plan aligned to the anthracycline chemotherapy (AC) cycles would be well tolerated, feasible, and attenuate the decline in peak oxygen uptake (V̇o2peak) in breast cancer (BC) patients. Twenty-eight women with early-stage BC treated with AC self-selected to undertake exercise training (EX 47 ± 9 years, n = 14) or usual care (53 ± 9 years, n = 14) for 12 weeks as part of a nonrandomized controlled trial. The periodized EX was aligned to the cyclic phases of AC, including AC taper and nontaper weeks. Outcome measures included cardiopulmonary exercise testing. Attendance and adherence variables (relative dose intensity [RDI] and volume load) were calculated to quantify the dose of EX completed relative to the amount of EX prescribed. The mean session attendance was 76% (range 46-88%). The mean ± SD prescribed and completed dose of aerobic training was 332.3 ± 48.7 MET h·wk-1 and 380.6 ± 53.2 MET h·wk-1 (p = 0.02), equating to a mean RDI of 89 ± 17%. For resistance training, the prescribed and completed cumulative dose was 128,264 ± 54,578 and 77,487 ± 26,108 kg (p < 0.001), equating to an RDI of 60 ± 11%. Adherence to the AC taper week RDI (52 ± 14%) for resistance training was significantly lower than the non-AC taper week (72 ± 8%, p = 0.02). The most frequent cause for EX interruption was hospitalization (35%), whereas AC-related illness was the most common cause for missed (57%) or modified EX sessions (64%). This periodized approach was mostly well tolerated for patients with BC. We speculate that a periodized approach may be both more palatable and useful, although this requires further investigation in a randomized controlled trial.

摘要

巴加拉恩、A、豪登、EJ、福克尔斯、S、扬森斯、K、博德里、R、海科尔斯基、MJ、拉热尔切、A、弗雷泽、SF 和塞利格、SE。在化疗期间为早期乳腺癌患者开具运动处方:一种与化疗周期相吻合的简单周期性方法。《力量与体能研究杂志》36(10):2934-2941,2022-评估一种与蒽环类化疗(AC)周期相吻合的有氧和抗阻训练方案是否能够被早期乳腺癌(BC)患者耐受、可行,并减缓峰值摄氧量(V̇o2peak)的下降。28 名接受 AC 治疗的早期 BC 女性患者选择参加为期 12 周的运动训练(EX:47±9 岁,n=14)或常规护理(53±9 岁,n=14),作为非随机对照试验的一部分。该周期性 EX 与 AC 的周期性阶段相吻合,包括 AC 减药和不减药周。主要结局指标包括心肺运动测试。计算出勤和依从性变量(相对剂量强度[RDI]和体积负荷)以量化相对于处方量完成的 EX 剂量。平均每次训练的出勤率为 76%(范围 46-88%)。规定和完成的有氧训练剂量平均值分别为 332.3±48.7MET h·wk-1和 380.6±53.2MET h·wk-1(p=0.02),相当于 RDI 为 89±17%。对于抗阻训练,规定和完成的累积剂量分别为 128264±54578kg 和 77487±26108kg(p<0.001),相当于 RDI 为 60±11%。抗阻训练中 AC 减药周 RDI(52±14%)的依从性明显低于非 AC 减药周(72±8%,p=0.02)。中断 EX 的最常见原因是住院(35%),而 AC 相关疾病是错过(57%)或修改 EX 课程(64%)的最常见原因。对于 BC 患者,这种周期性方法大多是可以耐受的。我们推测,虽然这需要在随机对照试验中进一步研究,但周期性方法可能更可口和有用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验